Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

Ketoconazole

Ketoconazole 400 mg / day

DRUG

BI 144807

BI144807 oral solution, intermediate dose

DRUG

BI 144807

BI144807 oral solution, intermediate dose

Trial Locations (1)

Unknown

1313.7.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY